N-3 PUFA
Side effects
Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | ||
|---|---|---|---|---|---|
| 1 | 2 | 3 | |||
| Dysgeusia | 4% | 1% | x | x | x |
| Eructation | 4% | 1% | x | x | x |
| Dyspepsia | 3% | 2% | x | x | x |
| Anaphylactic shock | postmarketing | x | x | x | |
| Haemorrhagic disorder | postmarketing | x | x | x | |
| Constipation | x | x | x | ||
| Rash | x | x | x | ||
| Gastrointestinal disorder | x | x | x | ||
| Pruritus | x | x | x | ||
| Vomiting | x | x | x | ||
| Aspartate aminotransferase increased | x | x | x | ||
| Alanine aminotransferase increased | x | x | x | ||
| Malnutrition | x | x | x | ||
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Color scheme:
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |
